Central Nervous System Melanoma
1 clinical trials · Condition
◉ Watch Central Nervous System Melanoma
| Record | Firm | Date |
|---|---|---|
| Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease (NCT03025256) | M.D. Anderson Cancer Center | 2018-05-02 |
Track Central Nervous System Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.